HDAC inhibitors as a novel approach to modulate the cancer stein cell phenotype

被引：0
|
作者：
Shabason, J. [1 ]
Dowling, M. L. [1 ]
Maquilan, G. [1 ]
Malkowicz, S. B. [1 ]
Geiger, G. A. [1 ]
Kao, G. D. [1 ]
机构：
[1] Hosp Univ Penn, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.832
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [1] HDAC inhibitors modulate immune checkpoint blockade in breast cancer
    Barberio, Manuela Terranova
    Thomas, Scott
    Ali, Niwa H.
    Park, Jeenah
    Rosenblum, Michael D.
    Budillon, Alfredo
    Munster, Pamela N.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [2] Enhancing anti-cancer capacity: Novel class I/II HDAC inhibitors modulate EMT, cell cycle, and apoptosis pathways
    Lee, Hsueh-Yun
    Hsu, Min-Jung
    Chang, Hao-Hsien
    Chang, Wei-Chiao
    Huang, Wan-Chen
    Cho, Er-Chieh
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 109
  • [3] A novel approach to assess the efficacy of HDAC inhibitors in vivo
    Soner, Altiok
    Gemmer, Jennifer
    Brazelle, William
    Haura, Eric
    CANCER RESEARCH, 2009, 69
  • [4] HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer
    Lin, Ting-, I
    Tseng, Yi-Ru
    Dong, Min-Jyun
    Lin, Chih-Yi
    Chung, Wei-Ting
    Liu, Chun-Yu
    Tsai, Yi-Fang
    Huang, Chi-Cheng
    Tseng, Ling-Ming
    Chao, Ta-Chung
    Lai, Jiun-, I
    CLINICAL EPIGENETICS, 2025, 17 (01)
  • [5] HDAC Inhibitors as Novel Anti-Cancer Therapeutics
    De Souza, Cristabelle
    Chatterji, Biswa P.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2015, 10 (02) : 145 - 162
  • [6] Targeting dysregulated cell differentiation in triple-negative breast cancer - an innovative approach using novel HDAC-inhibitors
    Esser, K.
    Kulik, A.
    Niederacher, D.
    Neubauer, H.
    Kurz, T.
    Fehm, T.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E96 - E96
  • [7] HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
    Miranda E. Clements
    Lauren Holtslander
    Courtney Edwards
    Vera Todd
    Samuel D. R. Dooyema
    Kennady Bullock
    Kensey Bergdorf
    Cynthia A. Zahnow
    Roisin M. Connolly
    Rachelle W. Johnson
    Oncogene, 2021, 40 : 5314 - 5326
  • [8] HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer
    Clements, Miranda E.
    Holtslander, Lauren
    Edwards, Courtney
    Todd, Vera
    Dooyema, Samuel D. R.
    Bullock, Kennady
    Bergdorf, Kensey
    Zahnow, Cynthia A.
    Connolly, Roisin M.
    Johnson, Rachelle W.
    ONCOGENE, 2021, 40 (34) : 5314 - 5326
  • [9] Development of Novel Proteasome-HDAC6 Hybrid Inhibitors for Resistant ALL Phenotype
    Bhatia, Sanil
    Ressing, Nina
    Herrlich, Alexandra
    Borkhardt, Arndt
    Hansen, Finn
    Hauer, Julia
    BLOOD, 2017, 130
  • [10] Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
    Gray, Jhanelle
    Cubitt, Christopher L.
    Zhang, Shumin
    Chiappori, Alberto
    CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 614 - 622
12345